SARS-CoV-2 Anti-S an Anti-N IgG Seropositivity in Children and Young People (1-24 Years) According to HIV Status in Lome (Togo) in 2022
Idioma
EN
Article de revue
Este ítem está publicado en
Influenza and Other Respiratory Viruses. 2025-04-01, vol. 19, n° 4, p. e70112
Resumen en inglés
We aimed to estimate SARS-CoV-2 seropositivity among children and young people in Lome, Togo, according to HIV status. A multicenter comparative cross-sectional study was conducted, and 636 participants were included (41.8% ...Leer más >
We aimed to estimate SARS-CoV-2 seropositivity among children and young people in Lome, Togo, according to HIV status. A multicenter comparative cross-sectional study was conducted, and 636 participants were included (41.8% living with HIV). Anti-S (88.7% vs. 89.1%) and anti-N (41.6% vs. 39.5%) IgG seropositivity were comparable in both groups. These data suggest no increased COVID-19 susceptibility in children and young people with HIV.< Leer menos
Palabras clave en inglés
HIV
SARS‐Cov‐2
Seropositivity
Young People
Centros de investigación